Acute radiation skin toxicity possible with BRAF inhibitors

“Unanticipated” acute radiation skin toxicity can occur in patients with metastatic melanoma undergoing radiotherapy with concomitant use of the BRAF inhibitors vemurafenib (Zelboraf, Roche) or dabrafenib (Tafinlar, GlaxoSmithKline), oncologists from Australia report.

MedScape